Verastem (VSTM) Operating Margin Growth (3y) (2021 - 2024)

Verastem (VSTM) Operating Margin Growth (3y) (2021 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 9,942.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Verastem 607.94 Mn 410.11 Mn 15.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 300,603.00
Mar 31, 2022 142,072.00
Dec 31, 2021 -19,822.00
Sep 30, 2021 -74.22 Mn
Jun 30, 2021 -300,686.00